Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ophthotech completes its $30mm Series B round

Executive Summary

Ophthotech (developing wet and dry age-related macular degeneration therapeutics) has closed its $30mm Series B venture round. Clarus Ventures led (and contributes a board member) and was joined by current shareholders SV Life Sciences, Novo AS, and HBM BioVentures. The company will use the funds for a Phase II study of E10030, a PDGF-targeting compound for wet AMD.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies